Quick Answer
Pharma-Bio Serv, Inc. reported Operating Income of -$637.7 thousand for fiscal year 2025.
Pharma-Bio Serv, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$637.7K | +50.5% |
| 2024 | -$1.29M | -215.2% |
| 2023 | $1.12M | -4.9% |
| 2022 | $1.17M | +130.5% |
| 2021 | -$3.85M | -273.2% |
| 2020 | $2.23M | +31.2% |
| 2019 | $1.70M | +234.5% |
| 2018 | -$1.26M | -62.2% |
| 2017 | -$777.8K | -747.7% |
| 2016 | -$91.8K | -105.2% |
| 2015 | $1.78M | -37.8% |
| 2014 | $2.86M | -52.8% |
| 2013 | $6.07M | +5.9% |
| 2012 | $5.73M | +66.1% |
| 2011 | $3.45M | +466.0% |
| 2010 | $609.9K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$94.5K | -2.5% | +69.9% |
| July 31, 2025 | -$313.9K | +17.8% | -219.2% |
| April 30, 2025 | -$98.3K | +68.6% | -6.7% |
| January 31, 2025 | -$92.2K | +79.0% | +75.9% |
| July 31, 2024 | -$381.8K | -182.9% | -21.8% |
| April 30, 2024 | -$313.4K | -182.5% | +28.5% |
| January 31, 2024 | -$438.3K | -233.4% | -195.2% |
| July 31, 2023 | $460.5K | +24.6% | +21.2% |
- Pharma-Bio Serv, Inc. showed an increase of +50.5% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, Pharma-Bio Serv, Inc.’s operating income has declined by 204.6% (from $609.9 thousand to -$637.7 thousand).
- The most recent figure is from Pharma-Bio Serv, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: